Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04807205 · ClinicalTrials.gov registry record · NA
Post Market Study Using The Elite IQ Device
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04807205 is a NA study that has completed, run by Cynosure. The registered enrollment target is 20 participants.
The verdict
NCT04807205, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a prospective, open label, single-center clinical study to collect safety and efficacy data on the Elite iQ workstation. The intended use of the Elite iQ device used in this study is for the treatment of hair removal, pseudo folliculitis barbae, and benign vascular and pigmented lesions.
Interventions
- DEVICE RF Non-Invasive Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-03-26 |
| Est. Completion | 2022-03-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04807205
The ClinicalTrials.gov registry entry for NCT04807205 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cynosure, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RF Non-Invasive Treatment is the first listed.
NCT04807205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04807205 about?
NCT04807205 is a clinical study titled "Post Market Study Using The Elite IQ Device". This is a prospective, open label, single-center clinical study to collect safety and efficacy data on the Elite iQ workstation. The intended use of the Elite iQ device used in this study is for the treatment of hair removal, pseudo folliculitis barbae, and benign vascular and pigmented lesions.
What is the current status of trial NCT04807205?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-03-26. Estimated completion is 2022-03-02.
What interventions are being tested in trial NCT04807205?
The interventions under investigation include: RF Non-Invasive Treatment (DEVICE).
Who is sponsoring clinical trial NCT04807205?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.